NCT06780670 2026-04-16
PSMAcTION
Novartis
Phase 2/3 Recruiting
Clinical Trials
28 trialsNCT05987241 2026-04-15
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
National Cancer Institute (NCI)
Phase 2/3 Recruiting
NCT07106762 2026-04-15
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Bristol-Myers Squibb
Phase 2/3 Recruiting
NCT04628767 2026-04-14
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
National Cancer Institute (NCI)
Phase 2/3 Recruiting
NCT04787744 2026-04-08
VA STARPORT
VA Office of Research and Development
Phase 2/3 Recruiting
NCT07426055 2026-03-23
PRO-BOOST-LC
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Recruiting
NCT07426094 2026-03-23
PRO-BOOST-N
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Recruiting
NCT06282588 2026-03-19
THUNDER
Cancer Research Antwerp
Phase 2/3 Recruiting
NCT07129993 2026-03-19
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Daiichi Sankyo
Phase 2/3 Recruiting
NCT03495427 2026-03-02
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
H. Lee Moffitt Cancer Center and Research Institute
Phase 2/3 Recruiting
NCT03258320 2026-01-12
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine
Phase 2/3 Recruiting
NCT03701581 2025-12-17
4-aminopyridine Treatment for Nerve Injury
University of Arizona
Phase 2/3 Recruiting
NCT06851663 2025-12-08
Trop2-targeted immunoPET Imaging of Solid Tumors
RenJi Hospital
Phase 2/3 Recruiting
NCT05786716 2025-12-02
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT05770037 2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT06861192 2025-11-18
Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer
Zhongda Hospital
Phase 2/3 Recruiting
NCT04263025 2025-10-22
AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft
Hackensack Meridian Health
Phase 2/3 Recruiting
NCT07209878 2025-10-07
68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
First Affiliated Hospital of Fujian Medical University
Phase 2/3 Recruiting
NCT06124976 2025-09-15
Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma
University of British Columbia
Phase 2/3 Recruiting
NCT06537154 2025-07-30
NEO-BLAST
University of British Columbia
Phase 2/3 Recruiting
NCT05920343 2025-07-10
PREVENT-GU
Ottawa Hospital Research Institute
Phase 2/3 Recruiting
NCT06879145 2025-06-18
Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2/3 Recruiting
NCT06972511 2025-05-15
Maximal Tumor Eradication for Oligometastatic Prostate Cancer
RenJi Hospital
Phase 2/3 Recruiting
NCT06493552 2025-04-03
Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors
Vasgene Therapeutics, Inc
Phase 2/3 Recruiting
NCT05381103 2025-01-31
PSMA-PET to Guide Prostatectomy
Five Eleven Pharma, Inc.
Phase 2/3 Recruiting
NCT03755739 2024-06-25
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Phase 2/3 Recruiting
NCT04242017 2023-12-13
LOBSTER
Universitaire Ziekenhuizen KU Leuven
Phase 2/3 Recruiting
NCT04654338 2023-06-27
EARTH
Sunnybrook Health Sciences Centre
Phase 2/3 Recruiting